Serial BNP Testing for Heart Failure Management
Stopped early
Conditions studied: Heart Failure
In brief
The scope of the USE-BNP Trial is to investigate whether knowledge of BNP measurements, in conjunction with clinical assessment, in the outpatient setting can guide the management of therapy in patients with heart failure.
Key facts
- Study ID
- NCT00622531
- Run by
- Siemens Healthcare Diagnostics Inc
- People needed
- 108
- Starts
- 2007-01-01
- Expected to finish
- 2009-07-01
- Last updated by the study team
- 2015-11-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Eligible subjects must be diagnosed with heart failure and have an abnormal BNP reading.
Where it is running
- Palo Alto VA Health Care System — Palo Alto, California, United States
- Bellevue Hospital — New York, New York, United States
- The Hudson Valley Heart Center — Poughkeepsie, New York, United States
- Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States
- UT Southwestern Medical Center — Dallas, Texas, United States
- Virginia Research Institute — Danville, Virginia, United States
- Centre Hospitalier Universitaire de Sherbrooke — Fleurimont, Quebec, Canada
- Centre Hospitalier de l'Université de Montréal (CHUM) Hôpital Hôtel Dieu — Montreal, Quebec, Canada
- McGill University Health Centre (MUHC) Royal Victoria Hospital — Montreal, Quebec, Canada
- McGill University Health Centre (MUHC) Montreal General Hospital — Montreal, Quebec, Canada
- Centre de santé et de services sociaux région de Thetford — Thetford-Mines, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.